{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:29:09Z","timestamp":1790800149495,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860306"],"award-info":[{"award-number":["81860306"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2019FE001"],"award-info":[{"award-number":["2019FE001"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Psychiatric disorders such as anxiety and depression precipitated by substance use occurred during both use and withdrawal. Exosomes play significant roles in biological functions and regulate numerous physiological and pathological processes in various diseases, in particular substance use disorders (SUDs) and other psychiatric disorders. To better understand the role of exosomal miRNAs in the pathology of symptoms of anxiety and depression in patients with SUDs, we first isolated circulating exosomes from heroin-dependent patients (HDPs) and methamphetamine-dependent patients (MDPs) and identified exosomal miRNAs that were differentially expressed between patients and healthy controls (HCs). Furthermore, the correlations between exosomal DE-miRNAs and symptoms of anxiety and depression which were measured using Hamilton-Anxiety (HAM-A)\/Hamilton-Depression (HAM-D) Rating Scales in the participants. Notably, the expression level of exosomal hsa-miR-16-5p, hsa-miR-129-5p, hsa-miR-363-3p, and hsa-miR-92a-3p showed significantly negative correlations with HAM-A scores in both HDPs and MDPs. But all of the 4 DE-miRNAs lost significant correlations with HAM-D scores in HDPs. Functional annotation analyses showed that the target genes of the DE-miRNAs were mainly enriched for \u201csynapse\u201d, \u201ccell adhesion\u201d, \u201cfocal adhesion\u201d and \u201cMHC class II protein complex\u201d. Our study suggests that a set of circulating exosomal miRNAs were associated with anxiety and depression in SUD patients and may have clinical utility as diagnostic and prognostic biomarkers.<\/jats:p>","DOI":"10.1038\/s41598-021-84501-5","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T16:47:41Z","timestamp":1616086061000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Prognostic plasma exosomal microRNA biomarkers in patients with substance use disorders presenting comorbid with anxiety and depression"],"prefix":"10.1038","volume":"11","author":[{"given":"Fengrong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenrong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juehua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"84501_CR1","unstructured":"World Drug Report 2019, United Nations publication. Sales No. E.19.XI.8 (2019)."},{"key":"84501_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fpsyt.2018.00256","volume":"9","author":"G Zhang","year":"2018","unstructured":"Zhang, G. et al. Estimating prevalence of illicit drug use in Yunnan, China, 2011\u20132015. Front. Psychiatry. 9, 256\u2013263 (2018).","journal-title":"Front. Psychiatry."},{"key":"84501_CR3","unstructured":"Malin, L. Director of Health and Family Planning Commission of Yunnan Province. MMT have taken remarkable effects. People.cn. Available online at http:\/\/yn.people.com.cn\/n2\/2017\/0626\/c372456-30380997.html (2019)."},{"key":"84501_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12028-008-9177-5","volume":"10","author":"EL Ho","year":"2009","unstructured":"Ho, E. L., Josephson, S. A., Lee, H. S. & Smith, W. S. Cerebrovascular complications of methamphetamine abuse. Neurocrit. Care. 10, 295\u2013305 (2009).","journal-title":"Neurocrit. Care."},{"issue":"12","key":"84501_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/clc.22195","volume":"36","author":"S Won","year":"2013","unstructured":"Won, S., Hong, R. A., Shohet, R. V., Seto, T. B. & Parikh, N. I. Methamphetamine-associated cardiomyopathy. Clin. Cardiol. 36(12), 737\u2013742 (2013).","journal-title":"Clin. Cardiol."},{"key":"84501_CR6","doi-asserted-by":"publisher","first-page":"2036145","DOI":"10.1155\/2018\/2036145","volume":"2018","author":"D Guzel","year":"2018","unstructured":"Guzel, D., Yazici, A. B., Yazici, E. & Erol, A. Evaluation of immunomodulatory and hematologic cell outcome in heroin\/opioid addicts. J. Addict. 2018, 2036145 (2018).","journal-title":"J. Addict."},{"key":"84501_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.drugpo.2019.09.018","volume":"73","author":"G Moradi","year":"2019","unstructured":"Moradi, G. et al. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran. Int. J. Drug Policy. 73, 129\u2013134 (2019).","journal-title":"Int. J. Drug Policy."},{"issue":"1","key":"84501_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12954-019-0324-4","volume":"16","author":"M Baluku","year":"2019","unstructured":"Baluku, M., Wamala, T. & Muhangi, D. HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: Implications for policy and programming. Harm. Reduct. J. 16(1), 56\u201374 (2019).","journal-title":"Harm. Reduct. J."},{"issue":"1","key":"84501_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1360-0443.2009.02791.x","volume":"105","author":"M Sofuoglu","year":"2010","unstructured":"Sofuoglu, M. Cognitive enhancement as a pharmacotherapy target for stimulant addiction. Addiction 105(1), 38\u201348 (2010).","journal-title":"Addiction"},{"issue":"7","key":"84501_CR10","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","volume":"104","author":"CC Cruickshank","year":"2009","unstructured":"Cruickshank, C. C. & Dyer, K. R. A review of the clinical pharmacology of methamphetamine. Addiction 104(7), 1085\u20131099 (2009).","journal-title":"Addiction"},{"issue":"19","key":"84501_CR11","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","volume":"264","author":"DA Regier","year":"1990","unstructured":"Regier, D. A. et al. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the epidemiologic catchment area (ECA) study. JAMA 264(19), 2511\u20132518 (1990).","journal-title":"JAMA"},{"issue":"2","key":"84501_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/00952990.2010.543998","volume":"37","author":"MJ Mancino","year":"2011","unstructured":"Mancino, M. J., Gentry, B. W., Feldman, Z., Mendelson, J. & Oliveto, A. Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: A pilot field study. Am. J. Drug Alcohol Abuse 37(2), 131\u2013136 (2011).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"84501_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3389\/fpsyt.2018.00551","volume":"9","author":"H Gan","year":"2018","unstructured":"Gan, H. et al. A research of methamphetamine induced psychosis in 1430 individuals with methamphetamine use disorder: Clinical features and possible risk factors. Front. Psychiatry. 9, 551\u2013558 (2018).","journal-title":"Front. Psychiatry."},{"issue":"9","key":"84501_CR14","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1080\/10826084.2017.1416400","volume":"53","author":"M Mbaba","year":"2018","unstructured":"Mbaba, M. et al. Prevalence, diagnosis, and treatment rates of mood disorders among opioid users under criminal justice supervision. Subst. Use Misuse. 53(9), 1519\u20131528 (2018).","journal-title":"Subst. Use Misuse."},{"key":"84501_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jama.2016.2240","volume":"315","author":"MA Robb","year":"2016","unstructured":"Robb, M. A., McInnes, P. M. & Califf, R. M. Biomarkers and surrogate endpoints: Developing common terminology and definitions. JAMA 315, 1107\u20131108 (2016).","journal-title":"JAMA"},{"key":"84501_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3389\/fpsyt.2020.00432","volume":"11","author":"MS Garc\u00eda-Guti\u00e9rrez","year":"2020","unstructured":"Garc\u00eda-Guti\u00e9rrez, M. S. et al. Biomarkers in psychiatry: Concept, definition, types and relevance to the clinical reality. Front. Psychiatry. 11, 432\u2013445 (2020).","journal-title":"Front. Psychiatry."},{"key":"84501_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpsychires.2019.09.002","volume":"119","author":"J Tomasi","year":"2019","unstructured":"Tomasi, J. et al. Towards precision medicine in generalized anxiety disorder: Review of genetics and pharmaco(epi)genetics. J. Psychiatr. Res. 119, 33\u201347 (2019).","journal-title":"J. Psychiatr. Res."},{"key":"84501_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbr.2017.12.004","volume":"346","author":"F Kader","year":"2018","unstructured":"Kader, F., Ghai, M. & Maharaj, L. The effects of DNA methylation on human psychology. Behav. Brain Res. 346, 47\u201365 (2018).","journal-title":"Behav. Brain Res."},{"key":"84501_CR19","doi-asserted-by":"publisher","first-page":"101830","DOI":"10.1016\/j.cpr.2020.101830","volume":"77","author":"MA Schiele","year":"2020","unstructured":"Schiele, M. A., Gottschalk, M. G. & Domschke, K. The applied implications of epigenetics in anxiety, affective and stress-related disorders\u2014A review and synthesis on psychosocial stress, psychotherapy and prevention. Clin. Psychol. Rev. 77, 101830 (2020).","journal-title":"Clin. Psychol. Rev."},{"key":"84501_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03542-7","author":"R Narayanan","year":"2020","unstructured":"Narayanan, R. & Schratt, G. miRNA regulation of social and anxiety-related behaviour. Cell Mol. Life Sci. https:\/\/doi.org\/10.1007\/s00018-020-03542-7 (2020).","journal-title":"Cell Mol. Life Sci."},{"key":"84501_CR21","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan, V. & Nestler, E. J. The molecular neurobiology of depression. Nature 455, 894\u2013902 (2008).","journal-title":"Nature"},{"issue":"1","key":"84501_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pnpbp.2012.05.018","volume":"39","author":"S Chiba","year":"2012","unstructured":"Chiba, S. et al. Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex. Prog. Neuropsychopharmacol. Biol. Psychiatry. 39(1), 112\u2013119 (2012).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"84501_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrd3366","volume":"10","author":"AH Nagahara","year":"2011","unstructured":"Nagahara, A. H. & Tuszynski, M. H. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat. Rev. Drug Discov. 10, 209\u2013219 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"84501_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.drugalcdep.2018.08.036","volume":"193","author":"F Ornell","year":"2018","unstructured":"Ornell, F. et al. Brain-derived neurotrophic factor in substance use disorders: A systematic review and meta-analysis. Drug Alcohol Depend. 193, 91\u2013103 (2018).","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"84501_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41398-018-0245-0","volume":"8","author":"JJ Chen","year":"2018","unstructured":"Chen, J. J. et al. Urinary biomarker panel for diagnosing patients with depression and anxiety disorders. Transl. Psychiatry. 8(1), 192\u2013200 (2018).","journal-title":"Transl. Psychiatry."},{"key":"84501_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jad.2018.02.039","volume":"232","author":"HS Yoon","year":"2018","unstructured":"Yoon, H. S., Hattori, K., Sasayama, D. & Kunugi, H. Low cocaine- and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients. J. Affect Disord. 232, 134\u2013138 (2018).","journal-title":"J. Affect Disord."},{"issue":"10","key":"84501_CR27","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.euroneuro.2017.07.009","volume":"27","author":"Z Iscan","year":"2017","unstructured":"Iscan, Z. et al. A positron emission tomography study of the serotonergic system in relation to anxiety in depression. Eur. Neuropsychopharmacol. 27(10), 1011\u20131021 (2017).","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"10043","key":"84501_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 388(10043), 505\u2013517 (2016).","journal-title":"Lancet"},{"key":"84501_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fpsyt.2020.00315","volume":"11","author":"F Navarrete","year":"2020","unstructured":"Navarrete, F. et al. Endocannabinoid system components as potential biomarkers in psychiatry. Front. Psychiatry. 11, 315\u2013344 (2020).","journal-title":"Front. Psychiatry."},{"issue":"2","key":"84501_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel, D. P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116(2), 281\u2013297 (2004).","journal-title":"Cell"},{"issue":"1","key":"84501_CR31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/imr.12059","volume":"253","author":"Y Bronevetsky","year":"2013","unstructured":"Bronevetsky, Y. & Ansel, K. M. Regulation of miRNA biogenesis and turnover in the immune system. Immunol. Rev. 253(1), 304\u2013316 (2013).","journal-title":"Immunol. Rev."},{"issue":"1","key":"84501_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-018-0897-7","volume":"17","author":"Z Sun","year":"2018","unstructured":"Sun, Z. et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol. Cancer. 17(1), 147\u2013165 (2018).","journal-title":"Mol. Cancer."},{"issue":"3","key":"84501_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2174\/2211536602666131118224225","volume":"2","author":"N Dahiya","year":"2014","unstructured":"Dahiya, N. & Atreya, C. D. MicroRNAs and major blood-borne infectious viral diseases. Microrna. 2(3), 212\u2013218 (2014).","journal-title":"Microrna."},{"key":"84501_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-019-09892-9","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. Heroin abuse and\/or HIV infection dysregulate plasma exosomal miRNAs. J. Neuroimmune Pharmacol. https:\/\/doi.org\/10.1007\/s11481-019-09892-9 (2019).","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"3","key":"84501_CR35","first-page":"2549","volume":"20","author":"M Wang","year":"2019","unstructured":"Wang, M. et al. Abnormal expression of circRNA_089763 in the plasma exosomes of patients with post-operative cognitive dysfunction after coronary artery bypass grafting. Mol. Med. Rep. 20(3), 2549\u20132562 (2019).","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"84501_CR36","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1002\/jcb.26599","volume":"119","author":"J Tavakolizadeh","year":"2018","unstructured":"Tavakolizadeh, J. et al. MicroRNAs and exosomes in depression: Potential diagnostic biomarkers. J. Cell Biochem. 119(5), 3783\u20133797 (2018).","journal-title":"J. Cell Biochem."},{"key":"84501_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuroscience.2019.03.027","volume":"408","author":"BG Berardino","year":"2019","unstructured":"Berardino, B. G. et al. Exposure to enriched environment rescues anxiety-like behavior and miRNA deregulated expression induced by perinatal malnutrition while altering oligodendrocyte morphology. Neuroscience 408, 115\u2013134 (2019).","journal-title":"Neuroscience"},{"key":"84501_CR38","first-page":"185","volume":"42","author":"CP Murphy","year":"2019","unstructured":"Murphy, C. P. & Singewald, N. Role of microRNAs in anxiety and anxiety-related disorders. Curr. Top Behav. Neurosci. 42, 185\u2013219 (2019).","journal-title":"Curr. Top Behav. Neurosci."},{"key":"84501_CR39","first-page":"5062","volume":"13","author":"HC Li","year":"2018","unstructured":"Li, H. C. et al. Expression of miRNAs in serum exosomes versus hippocampus in methamphetamine-induced rats and intervention of rhynchophylline. Evid. Based Complement. Alternat. Med. 13, 5062 (2018).","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"4","key":"84501_CR40","first-page":"3369","volume":"15","author":"HC Li","year":"2018","unstructured":"Li, H. C. et al. Expression of microRNAs in the serum exosomes of methamphetamine-dependent rats vs. ketamine-dependent rats. Exp. Ther. Med. 15(4), 3369\u20133375 (2018).","journal-title":"Exp. Ther. Med."},{"key":"84501_CR41","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/npp.2008.131","volume":"34","author":"R Zhou","year":"2009","unstructured":"Zhou, R. et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology. 34, 1395\u20131405 (2009).","journal-title":"Neuropsychopharmacology."},{"key":"84501_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neulet.2012.03.062","volume":"516","author":"S Katsuura","year":"2012","unstructured":"Katsuura, S. et al. microRNAs miR-144\/144* and miR-16 in peripheral blood are potential biomarkers for naturalistic stress in healthy Japanese medical students. Neurosci. Lett. 516, 79\u201384 (2012).","journal-title":"Neurosci. Lett."},{"key":"84501_CR43","doi-asserted-by":"publisher","first-page":"e0121975","DOI":"10.1371\/journal.pone.0121975","volume":"10","author":"Y Wan","year":"2015","unstructured":"Wan, Y. et al. Identification of differential microRNA since rebrospinal fluidand serum of patients with major depressive disorder. PLoS ONE 10, e0121975 (2015).","journal-title":"PLoS ONE"},{"key":"84501_CR44","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.exger.2014.03.002","volume":"56","author":"MR Rippo","year":"2014","unstructured":"Rippo, M. R. et al. MitomiRs in human inflamm-aging: A hypothesis involving miR-181a, miR-34a and miR-146a. Exp Gerontol. 56, 154\u2013163 (2014).","journal-title":"Exp Gerontol."},{"issue":"1","key":"84501_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cns.12655","volume":"23","author":"M Golpich","year":"2017","unstructured":"Golpich, M. et al. Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: Pathogenesis and treatment. CNS Neurosci Ther. 23(1), 5\u201322 (2017).","journal-title":"CNS Neurosci Ther."},{"issue":"9","key":"84501_CR46","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.tins.2019.07.002","volume":"42","author":"MD Filiou","year":"2019","unstructured":"Filiou, M. D. & Sandi, C. Anxiety and brain mitochondria: A bidirectional crosstalk. Trends Neurosci. 42(9), 573\u2013588 (2019).","journal-title":"Trends Neurosci."},{"key":"84501_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuroscience.2013.01.041","volume":"264","author":"DM Fass","year":"2014","unstructured":"Fass, D. M., Schroeder, F. A., Perlis, R. H. & Haggarty, S. J. Epigenetic mechanisms in mood disorders: Targeting neuroplasticity. Neuroscience 264, 112\u2013130 (2014).","journal-title":"Neuroscience"},{"key":"84501_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/jrms.JRMS_879_17","volume":"23","author":"A Gheysarzadeh","year":"2018","unstructured":"Gheysarzadeh, A. et al. Serum-based microRNA biomarkers for major depression: MiR-16, miR-135a, and miR-1202. J. Res. Med. Sci. 23, 69\u201373 (2018).","journal-title":"J. Res. Med. Sci."},{"key":"84501_CR49","doi-asserted-by":"publisher","first-page":"e75960","DOI":"10.1371\/journal.pone.0075960","volume":"8","author":"M Honda","year":"2013","unstructured":"Honda, M. et al. Chronic academic stress increases a group of microRNAs in peripheral blood. PLoS ONE 8, e75960 (2013).","journal-title":"PLoS ONE"},{"key":"84501_CR50","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jad.2018.06.034","volume":"238","author":"QY Shao","year":"2018","unstructured":"Shao, Q. Y. et al. CSF miR-16 expression and its association with miR-16 and serotonin transporter in the raphe of a rat model of depression. J. Affect. Disord. 238, 609\u2013614 (2018).","journal-title":"J. Affect. Disord."},{"key":"84501_CR51","doi-asserted-by":"publisher","first-page":"e46921","DOI":"10.1371\/journal.pone.0046921","volume":"7","author":"M Bai","year":"2012","unstructured":"Bai, M. et al. Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life. PLoS ONE 7, e46921 (2012).","journal-title":"PLoS ONE"},{"key":"84501_CR52","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fnins.2017.00428","volume":"11","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. miR-16 and fluoxetine both reverse autophagic and apoptotic change in chronic unpredictable mild stress model rats. Front. Neurosci. 11, 428\u2013445 (2017).","journal-title":"Front. Neurosci."},{"issue":"6","key":"84501_CR53","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1055\/s-2001-20406","volume":"32","author":"R Kristjansdottir","year":"2001","unstructured":"Kristjansdottir, R., Uvebrant, P. & Rosengren, L. Glial fibrillary acidic protein and neurofilament in children with cerebral white matter abnormalities. Neuropediatrics. 32(6), 307 (2001).","journal-title":"Neuropediatrics."},{"key":"84501_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fncel.2015.00040","volume":"9","author":"A Cattaneo","year":"2015","unstructured":"Cattaneo, A. et al. Inflammation and neuronal plasticity: A link between childhood trauma and depression pathogenesis. Front. Cell Neurosci. 9, 40\u201351 (2015).","journal-title":"Front. Cell Neurosci."},{"key":"84501_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tox.2014.12.011","volume":"328","author":"AA Elnar","year":"2015","unstructured":"Elnar, A. A., Desor, F., Marin, F., Soulimani, R. & Nemos, C. Lactational exposure to low levels of the six indicator non-dioxin-like polychlorinated biphenyls induces DNA damage and repression of neuronal activity, in juvenile male mice. Toxicology 328, 57\u201365 (2015).","journal-title":"Toxicology"},{"issue":"3","key":"84501_CR56","doi-asserted-by":"publisher","first-page":"e32969","DOI":"10.1371\/journal.pone.0032969","volume":"7","author":"R Yadav","year":"2012","unstructured":"Yadav, R. et al. Deletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviors. PLoS ONE 7(3), e32969 (2012).","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"84501_CR57","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.1016\/j.psyneuen.2009.05.021","volume":"34","author":"EB Binder","year":"2009","unstructured":"Binder, E. B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psycho. Neuroendocrinol. 34(Suppl 1), S186\u2013S195 (2009).","journal-title":"Psycho. Neuroendocrinol."},{"issue":"8","key":"84501_CR58","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.3390\/ijms18081810","volume":"18","author":"YT Lin","year":"2017","unstructured":"Lin, Y. T. et al. NPFFR2 activates the HPA axis and induces anxiogenic effects in rodents. Int. J. Mol. Sci. 18(8), 1810\u20131822 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"84501_CR59","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/1099-1077(200008)15:6<397::AID-HUP212>3.0.CO;2-L","volume":"15","author":"M Naughton","year":"2000","unstructured":"Naughton, M., Mulrooney, J. B. & Leonard, B. E. A review of the role of serotonin receptors in psychiatric disorders. Hum. Psychopharmacol. 15, 397\u2013415 (2000).","journal-title":"Hum. Psychopharmacol."},{"key":"84501_CR60","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S0006-3223(02)01383-5","volume":"52","author":"V Klimek","year":"2002","unstructured":"Klimek, V., Schenck, J. E., Han, H., Stockmeier, C. A. & Ordway, G. A. Dopaminergic abnormalities in amygdaloid nuclei in major depression: A post-mortem study. Biol. Psychiatry. 52, 740\u2013748 (2002).","journal-title":"Biol. Psychiatry."},{"issue":"5","key":"84501_CR61","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1073\/pnas.1719014115","volume":"115","author":"M Heshmati","year":"2018","unstructured":"Heshmati, M. et al. Cell-type-specific role for nucleus accumbens neuroligin-2 in depression and stress susceptibility. Proc. Natl. Acad. Sci. 115(5), 1111\u20131116 (2018).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"84501_CR62","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.hlc.2011.11.002","volume":"21","author":"BC Bernardo","year":"2012","unstructured":"Bernardo, B. C., Charchar, F. J., Lin, R. C. & McMullen, J. R. A microRNA guide for clinicians and basic scientists: Background and experimental techniques. Heart Lung Circ. 21(3), 131\u2013142 (2012).","journal-title":"Heart Lung Circ."},{"issue":"1","key":"84501_CR63","first-page":"7","volume":"7","author":"V Avecilla","year":"2019","unstructured":"Avecilla, V. & Avecilla, A. Inhibitor of DNA-binding\/differentiation proteins and environmental toxicants: Genomic impact on the onset of depressive dysfunction. Med. Sci. (Basel) 7(1), 7\u201317 (2019).","journal-title":"Med. Sci. (Basel)"},{"key":"84501_CR64","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton, M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 32, 50\u201355 (1959).","journal-title":"Br. J. Med. Psychol."},{"key":"84501_CR65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56\u201362 (1960).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"84501_CR66","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.23430","author":"AN B\u00f6ing","year":"2014","unstructured":"B\u00f6ing, A. N. et al. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J. Extracell Vesicles https:\/\/doi.org\/10.3402\/jev.v3.23430 (2014).","journal-title":"J. Extracell Vesicles"},{"issue":"1","key":"84501_CR67","doi-asserted-by":"publisher","first-page":"1596016","DOI":"10.1080\/20013078.2019.1596016","volume":"8","author":"D Bachurski","year":"2019","unstructured":"Bachurski, D. et al. Extracellular vesicle measurements with nanoparticle tracking analysis\u2014An accuracy and repeatability comparison between NanoSight NS300 and ZetaView. J. Extracell Vesicles. 8(1), 1596016 (2019).","journal-title":"J. Extracell Vesicles."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84501-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T05:25:59Z","timestamp":1670045159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84501-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["84501"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-84501-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"14 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6271"}}